This compound is a protected derivative of lysine, featuring both a 9-fluorenylmethoxycarbonyl (Fmoc) group on the alpha-amino group and a methyl-tert-butoxycarbonyl (Me,Boc) protected side-chain. It is primarily used as a building block in solid-phase peptide synthesis, enabling the sequential assembly of peptides with orthogonal protection schemes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 951695-85-5
N-Fmoc-N'-Boc-N'-isopropyl-L-lysine
pharmaceutical intermediate
Fmoc-N',N'-dimethyl-L-lysine hydrochloride
pharmaceutical intermediate
5-isothiocyanato-3-(trifluoromethyl)pyridine-2-carbonitrile
pharmaceutical intermediate
(2-Methyl-2H-indazol-5-yl)boronic acid
pharmaceutical intermediate
4-(Trifluoromethyl)cyclohexanecarboxylic acid
pharmaceutical intermediate
4-Amino-5-methyl-2(1H)-pyridinone
pharmaceutical intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]hexanoic acid
JHMSFOFHTAYQLS-QHCPKHFHSA-N
CC(C)(C)OC(=O)N(C)CCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13